Your browser doesn't support javascript.
loading
The development of an electrochemical immunosensor utilizing chicken IgY anti-spike antibody for the detection of SARS-CoV-2.
Al-Qaoud, Khaled M; Obeidat, Yusra M; Al-Omari, Tareq; Okour, Mohammad; Al-Omari, Mariam M; Ahmad, Mohammad I; Alshadfan, Raed; Rawashdeh, AbdelMonem M.
Afiliación
  • Al-Qaoud KM; Department of Biological Sciences, Faculty of Science, Yarmouk University, Irbid, Jordan.
  • Obeidat YM; Department of Electronics Engineering, Hijjawi Faculty for Engineering Technology, Yarmouk University, Irbid, Jordan. yusra.obeidat@yu.edu.jo.
  • Al-Omari T; Department of Biological Sciences, Faculty of Science, Yarmouk University, Irbid, Jordan.
  • Okour M; Department of Biological Sciences, Faculty of Science, Yarmouk University, Irbid, Jordan.
  • Al-Omari MM; Department of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, Jordan.
  • Ahmad MI; Rawgene Biotech, Umm Khelad St. 33, Amman, Jordan.
  • Alshadfan R; Atlas Medical, Sahab Industrial Area, Amman, Jordan.
  • Rawashdeh AM; Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal.
Sci Rep ; 14(1): 748, 2024 01 07.
Article en En | MEDLINE | ID: mdl-38185704
ABSTRACT
This paper introduces a novel approach for detecting the SARS-CoV-2 recombinant spike protein combining a label free electrochemical impedimetric immunosensor with the use of purified chicken IgY antibodies. The sensor employs three electrodes and is functionalized with an anti-S IgY antibody, ELISA and immunoblot assays confirmed the positive response of chicken immunized with SARS-CoV2 S antigen. The developed immunosensor is effective in detecting SARS-CoV-2 in nasopharyngeal clinical samples from suspected cases. The key advantage of this biosensor is its remarkable sensitivity, and its capability of detecting very low concentrations of the target analyte, with a detection limit of 5.65 pg/mL. This attribute makes it highly suitable for practical point-of-care (POC) applications, particularly in low analyte count clinical scenarios, without requiring amplification. Furthermore, the biosensor has a wide dynamic range of detection, spanning from 11.56 to 740 ng/mL, which makes it applicable for sample analysis in a typical clinical setting.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígenos de Grupos Sanguíneos / Técnicas Biosensibles / COVID-19 Tipo de estudio: Diagnostic_studies Límite: Animals Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígenos de Grupos Sanguíneos / Técnicas Biosensibles / COVID-19 Tipo de estudio: Diagnostic_studies Límite: Animals Idioma: En Año: 2024 Tipo del documento: Article